BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Europe

Vetter Expands Production Capacities and Services Offered at Its Austrian Site

Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), continues to drive the expansion of capacities and services for the pr...

May 09, 2023 | News

Biosynth Further Strengthens Peptide Business with Acquisition of Cambridge Research Biochemicals.

Biosynth, a supplier of critical raw materials to the life science industry, announces today that it has acquired Cambridge Research Biochemicals...

May 09, 2023 | News

Nouscom Reaches Clinical Phase II Using ProBioGen’s AGE1.CR.pIX® Production Platform

Nous-209 has been developed using the Nouscom's viral vector platform, which includes adenoviral and Modified Vaccinia Ankara (MVA) vectors, with MVA vecto...

May 04, 2023 | News

Full-Life Technologies Buys Land in Belgium for Radiopharmaceutical Manufacturing Facility.

"Production capability and capacity, as well as logistics challenges have been major bottlenecks to radiotherapeutic discovery and development," said Phili...

May 04, 2023 | News

MicrofluidX and Immatics working together on automated end-to-end bioprocessing for TCR-T therapies

MicrofluidX, a UK-based provider of next generation bioreactors for cell biology research and cell therapy manufacturing, today announces a joint research ...

May 03, 2023 | News

Eppendorf Partners with Clustermarket to Offer Integrated Lab Management Solution

Holistic IoT device and lab management solution With research and development being a time-consuming industry, there is a constant need for time-saving di...

May 02, 2023 | News

Melanoma Research Alliance awards $6.3M in grants for prevention, detection, and treatment

MRA-funded research spans the entire spectrum of the disease including melanoma prevention, diagnosis, treatment, and metastatic disease. Melanoma is the d...

May 02, 2023 | News

FDA Approves Teva and MedinCell's UZEDY™ for Adult Schizophrenia Treatment

This new treatment provides adults living with schizophrenia a long-acting formulation that offers flexible 1- and 2-month dosing intervals1 In a ...

May 01, 2023 | Regulatory

Merck Kicks Off 2023 Curiosity Cube Mobile Lab Tour

Over 250 events expected to reach more than 45,000 future scientists on two continents Hands-on experiments to focus on impact of contamination on the p...

April 30, 2023 | News

Exothera Forms Partnership with Quantoom Biosciences to Launch RNA Business Unit

Exothera has partnered with Quantoom Biosciences ("Quantoom") to gain access to Quantoom’s Nfinity technology, a continuous production platform for R...

April 27, 2023 | News

Roquette Cuts Ribbon on $25 Million Pharmaceutical Innovation Center in the United States

Staffed with a team of highly skilled research, application and formulation experts, the new $25 million center will be an advanced training and coll...

April 20, 2023 | News

Ajinomoto Bio-Pharma Services Receives FDA Approval for High Potency Fill Line

"Receiving FDA approval on our HPAPI fill line is an exciting milestone for our company, and couldn't have happened without the hard work, hours of prepara...

April 20, 2023 | News

BioSenic Granted Key European Patent for Therapeutic Development in Cancer and Immune Diseases

BioSenic’s new formulation lowers the dosage of arsenic trioxide by combining it with copper salts to ma...

April 18, 2023 | News

Scientists from Singapore and Sweden achieve promising results towards restoring vision in blindness caused by cellular degeneration in the eye

A preclinical study using stem cells to produce progenitor photoreceptor cells—light-detecting cells found in the eye—and then transplanting th...

April 17, 2023 | News

Stay Connected